Bio-Rad Laboratories (BIO.B) News Today → Bad week to own stocks - see this (From DTI) (Ad) Free BIO.B Stock Alerts $279.91 -58.64 (-17.32%) (As of 04/18/2024) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsSocial MediaStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO.B) Stock Price Down 17.3%Bio-Rad Laboratories (NYSE:BIO.B) Stock Price Down 17.3%May 8, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down to $338.55Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down to $338.55May 8, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Bio-Rad Laboratories (BIO), Caribou Biosciences (CRBU)May 8, 2024 | markets.businessinsider.comThe Analyst Landscape: 4 Takes On Bio-Rad LaboratoriesMay 1, 2024 | msn.comBio-Rad launches three StarBright Red Dyes and expands range of antibody markers conjugated to StarBright Violet Dyes to enhance immunology researchApril 30, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO.B) Sets New 12-Month Low at $268.80Bio-Rad Laboratories (NYSE:BIO.B) Sets New 1-Year Low at $268.80April 30, 2024 | marketbeat.comBio-Rad Laboratories (BIO.B) to Release Earnings on TuesdayBio-Rad Laboratories (NYSE:BIO.B) will be releasing earnings after the market closes on Tuesday, May 7, Zacks reports.April 25, 2024 | finance.yahoo.comOncology Market Expected to Grow at 9.6% CAGR, Reaching USD 533.2 Bn by 2032 | DMRApril 21, 2024 | finance.yahoo.comLyme Disease Diagnostic Market Research Report 2024: Global Trends, Forecasts and Competitive Analysis to 2030April 10, 2024 | businesswire.comBio-Rad’s Chief Operating Officer Andrew Last to RetireApril 9, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO.B) Shares Down 1.6% Bio-Rad Laboratories (NYSE:BIO.B) Trading Down 1.6%April 1, 2024 | finance.yahoo.comUnlocking Precision in Diagnosis: The Rise of Molecular Point-of-Care SolutionsApril 1, 2024 | uk.finance.yahoo.comGlobal Glucometer Market Projected to Reach $30.5 Billion by 2030, With a CAGR of 8.9%March 26, 2024 | msn.comBio-Rad launches validated antibodies for rare cell and circulating tumor cell enumerationMarch 17, 2024 | finance.yahoo.comBIO Apr 2024 350.000 putMarch 16, 2024 | finance.yahoo.comBIO Apr 2024 330.000 callMarch 14, 2024 | finanznachrichten.deInsightAce Analytics Pvt. Ltd.: Combo IVD Market worth $920.9 Mn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.February 27, 2024 | msn.comBio-Rad launches vericheck ddPCR replication competent lentivirus and replication competent AAV kits for cell and gene therapy productionFebruary 14, 2024 | markets.businessinsider.comBio-Rad Laboratories is about to announce earnings — here's what Wall Street expectsFebruary 6, 2024 | finance.yahoo.comRecombinant Proteins Market Worth $3.2 Billion | MarketsandMarkets™.February 5, 2024 | nz.finance.yahoo.comMeta's fake videos should be labelled, says boardJanuary 27, 2024 | markets.businessinsider.comRBC Capital Remains a Buy on Bio-Rad Laboratories (BIO)December 10, 2023 | businesswire.comBe Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-101, Produces Active and Sustained Levels of Factor IX for the Treatment of ...November 14, 2023 | msn.comBio-Rad (BIO) Hurt by Macroeconomic Woes, Margin PressureOctober 26, 2023 | finance.yahoo.comBio-Rad Laboratories (BIO) Q3 Earnings and Revenues Miss EstimatesOctober 26, 2023 | reuters.comBio-Rad Labs cuts 2023 revenue growth forecast as biotechs cut spendingSeptember 13, 2023 | thestreet.comBio-Rad Laboratories Inc. Class BJuly 26, 2023 | technews.tmcnet.comBio-Rad and QIAGEN announce patent settlement and cross-licensing agreementJune 16, 2023 | msn.comBio-Rad Laboratories (BIO) Dips More Than Broader Markets: What You Should KnowJune 16, 2023 | markets.businessinsider.comThe Latest Analyst Ratings for Bio-Rad LaboratoriesJune 9, 2023 | msn.comBio-Rad Laboratories (BIO) Outpaces Stock Market Gains: What You Should KnowMay 24, 2023 | msn.comDeath Cross Looms Over Bio-Rad Laboratories InvestorsMay 5, 2023 | msn.comCredit Suisse Maintains Bio-Rad Laboratories Inc. - (BIO) Outperform RecommendationMay 5, 2023 | msn.comBio-Rad’s stock leads the S&P 500 decliners, as they suffer the biggest selloff in 36 years after disappointing results.April 27, 2023 | msn.comBio-Rad Laboratories (BIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseApril 6, 2023 | markets.businessinsider.comNona Biosciences Enters into Collaboration Agreement with ExeVir BioMarch 22, 2023 | marketwatch.com2023-2029 Global Hepatitis B Testing Market Business ExplorationMarch 9, 2023 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Bio-Rad Laboratories (BIO) and Zimmer Biomet Holdings (ZBH)March 9, 2023 | msn.comBio-Rad (BIO) Global Expansion Strong, FX Woe Dents GrowthJanuary 15, 2023 | thestreet.comBio-Rad Laboratories (BIO) Upgraded From Hold to BuyDecember 20, 2022 | markets.businessinsider.comGT Molecular Releases Respiratory Panels and Poliovirus Typing Assays for Leading PCR PlatformsDecember 8, 2022 | yahoo.comAnimal health diagnostics market: Growth opportunities led by Bio Rad Laboratories Inc. and Bio X Diagnostics SA - TechnavioOctober 28, 2022 | msn.comBio-Rad (BIO) Q3 Earnings Surpass Estimates, Margins DownOctober 27, 2022 | msn.comBio-Rad Laboratories (BIO) Surpasses Q3 Earnings EstimatesOctober 11, 2022 | msn.comBio-Rad Laboratories, Qiagen Mull Merger Of EqualsOctober 10, 2022 | bizjournals.comEast Bay life sciences company reportedly in talks with Qiagen in $10 billion dealSeptember 29, 2022 | benzinga.comThe Global Flow Cytometry Market size is expected to reach $7.7 billion by 2028, rising at a market growth of 8.3% CAGR during the forecast periodJune 20, 2022 | finance.yahoo.comIs Bio-Rad Laboratories (NYSE:BIO) Using Too Much Debt?June 13, 2022 | thestreet.comBio-Rad Laboratories Inc. Class AMay 28, 2022 | finance.yahoo.comThe 4.8% return this week takes Bio-Rad Laboratories' (NYSE:BIO) shareholders five-year gains to 140% Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO.B and its competitors with MarketBeat's FREE daily newsletter. Email Address How this is some devastating news (Ad)Check out this report real quick… It’s full proof that most people barely have enough money to cover the monthly expenditures… Let alone save for retirement or plan the next vacation. At the risk of sounding political… If you’re waiting for the Fed, or the government or some financial advisor to come to change things for the better… You might be waiting for a long long time. But what if…? What if there was a way to completely turn the tables? But I can promise that you’ll see all the details for yourself here. BIO.B Media Mentions By Week BIO.B Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIO.B News Sentiment▼0.000.42▲Average Medical News Sentiment BIO.B News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIO.B Articles This Week▼10▲BIO.B Articles Average Week Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO.B and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BIO News Today TXG News Today OLK News Today RVTY News Today AVTR News Today ILMN News Today WAT News Today VKTX News Today LEGN News Today PEN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BIO.B) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMost important medical advance in 100 yearsThe Oxford ClubDems have chosen Biden replacement?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
